Meet with… Spectrum 28
There was a time when advice was all one should expect from a VC partner. It’s time to expect more.
Spectrum 28 is an early-stage venture capital firm investing in companies who leverage data and computation to create and transform large industries. They have a unique approach to investing by supporting startups that are disrupting industries at times of key inflection.
In September 2016, Spectrum 28 announced their $170 million debut fund, Spectrum Fund I. Each quarter, Spectrum 28 chooses one industry or investment area that the entire team collaborates on and they only invest if they can help a company do something beyond what they would otherwise be able to do without them. Investment areas include:
- Digital Health
Spectrum 28 Co-Founder and General Partner, Lyon Wong will be in attendance to give an overview presentation about the company’s key areas of interest. Following the presentation, don’t miss the opportunity to introduce yourself to Lyon during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Spectrum 28 will provide an intimate forum to discuss your company.
10:30 AM | Registration Opens and Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking Lunch
1:00-5:00 PM | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on January 19th.
Spectrum 28 Participating Representative:
Lyon Wong | Co-Founder and General Partner, Spectrum 28
Lyon is Co-Founder, Founding General Partner, and Partner at Spectrum 28 Capital LLC. He has been at the firm since August 2015. He is the Founder of three companies, ranging from SMB to Health-tech. He was Chief Executive Officer and Cofounder at Health Global Connect from 2009 till 2011. He has led several of the most critical areas of Microsoft Windows (Search and Storage) and was PM for Windows Vista and Windows 7 at Microsoft Corporation from 2004 to 2010. He was a Partner at Lightspeed Venture Partners. His experience combines investing and entrepreneurship. He has venture capital experience across the spectrum, from angel investment team SV Angel, where he was an Investment Intern form January 2012 till June 2013, to late-stage investment team Meritech Capital Partners. Mr. Wong has mentored teams from Stanford, Waterloo, Berkeley, Google, Microsoft, and Palantir. He has over 30 product, design and algorithm patents in Data Search, Storage, Visualization, Transfer and Analytics. Mr. Wong holds an MBA from the Stanford Graduate School of Business where he was Co-president of Venture Capital Club and Chief Operating Officer of Greater China Business Club. He also holds a Systems Design Engineering Degree from the University of Waterloo, with distinction; where he researched on autonomous robotics, machine learning and NLP.
Presentation & Lunch
CA$ 25 | General Public
CA$ 50 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on February 13th (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on January 19th. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of one-on-one meetings is not guaranteed as all applications must be approved.
About the Meet with… Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA’s Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
JLABS @ Toronto
MaRS Centre, West Tower
661 University Ave, Suite 1300 [13th Floor]